AGBGA. Artículos de Investigación

URI permanente para esta colección

https://repositorio.udes.edu.co/handle/001/9430

Navegar

Examinando AGBGA. Artículos de Investigación por Autor "Bayona Prieto, Jaime"

Mostrando 1 - 2 de 2
  • Publicación
    Acceso abierto
    Evaluación neurofuncional del tallo cerebral. Parte I : Reflejo del parpadeo
    (2009-10) Leon Sarmiento, Fidias E.; Gutiérrez, Claudia; Bayona Prieto, Jaime
    The blink reflex is the neural response elicited in the orbicular oculi muscle after single or paired supraorbital nerve stimulation, by either electrical, mechanical, acoustic, thermal, chemical or magnetic stimulation. It is made up of three responses called R1, R2 and R3. R1 is an early response that follows A beta fibers, and does not habituate. R2 is a middle-latency response that follows A beta and A delta fibers, tends to habituate and is modulated by sensorimotor suprasegmental structures. R3 is a long-latency response, generated by stimulation of a multisynaptic chain of neurons that involve type C fibers belonging to a complex pontothalamic-amigdalo-cerebellar pathway. It is also possible to record three silent periods if the blink reflex is obtained while the subject makes a voluntary facial muscle effort. The functional study of this reflex allows to define with certainty whether the lesion is in afferent or efferent pathways or if it involves an abnormal sensorimotor integration due to disorders of the central, autonomic or peripheral nervous systems. A correct execution of these studies, and their appropriate interpretation, based on the underlying mechanisms of neural plasticity, will guide toward better neurorehabilitation protocols.
  • Publicación
    Acceso abierto
    Smell status in functional movement disorders : New clues for diagnosis and underlying mechanisms
    (2019) Leon Sarmiento, Fidias E.; Bayona Prieto, Jaime; Leon Ariza, Juan S.; Leon Ariza, Daniel S.; Jacob, Alexandra E.; LaFaver, Kathrin; Doty, Richard L.
    Objective: Functional movement disorders (FMDs) mimic a range of movements, neuropsychiatric and neurodegenerative disorders known to have smell dysfunction, which has been neglected in terms of its application to FMD. We aim to determine the smell status in FMD patients tested by a non-invasive, reliable and validated olfactory test. Patients and methods: We quantitatively assessed in thirty-five FMD patients their smell status and compared it to that of healthy age- and sex-matched controls, and of patients with Parkinson’s disease (PD). All participants were administered the Brief Smell Identification Test (B-SIT), a standardized short version of the University of Pennsylvania Smell Identification Test (UPSIT). The Picture Identification Test (PIT), a visual test analogous in content and form to the UPSIT designed to control for non-olfactory cognitive confounds, was also administered. Results: The B-SIT scores of the FMD patients were higher than those from PD patients [respective means (standard deviations: SDs) = FMD, 9.54 (1.57); PD, 4.64 (1.05), p < 0.01)] but similar to the smell scores from healthy controls [9.97 (1.77), p=0.35]. Gender, age, time of disease onset, smoking status, and phenotypic expression did not influence the test scores. Fourteen FMD patients who mentioned having olfactory dysfunction before smell testing have their test results within normal range. PIT scores from patients and healthy controls were within normal range. Conclusions: These findings indicate that FMD patients have normal olfactory function. Olfactory testing may be helpful in identifying and differentiating FMD from other movement, neurodegenerative and neuropsychiatric diseases for which smell function is altered.